Tenet Healthcare (THC) PT Raised to $40 at Leerink Partners

Go back to Tenet Healthcare (THC) PT Raised to $40 at Leerink Partners

Tenet Healthcare (THC) PT Raised to $30 at RBC Capital

May 2, 2018 8:45 AM EDT

RBC Capital raised its price target on Tenet Healthcare (NYSE: THC) to $30.00 (from $21.00) while maintaining a Sector Perform rating.

Analyst Frank Morgan commented, "THC exceeded expectations and the high end of guidance for 1Q18, largely driven by outperformance at Conifer through accelerated cost... More

Tenet Healthcare (THC) PT Raised to $24 at Morgan Stanley

May 2, 2018 8:02 AM EDT

Morgan Stanley raised its price target on Tenet Healthcare (NYSE: THC) to $24.00 (from $16.00) while maintaining a Underweight rating.

... More

Tenet Healthcare (THC) PT Raised to $32 at SunTrust Robinson Humphrey

May 2, 2018 3:29 AM EDT

SunTrust Robinson Humphrey raised its price target on Tenet Healthcare (NYSE: THC) to $32.00 (from $27.00) while maintaining a Hold rating.

... More

Tenet Healthcare (THC) PT Raised to $28 at Jefferies

May 1, 2018 1:03 AM EDT

Jefferies raised its price target on Tenet Healthcare (NYSE: THC) to $28.00 (from $23.00) while maintaining a Buy rating.

... More